Daniel Stauder
Stock Analyst at JMP Securities
(3.21)
# 1,148
Out of 4,667 analysts
7
Total ratings
50%
Success rate
19.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Initiates: Market Outperform | $33 | $27.17 | +21.46% | 1 | Oct 23, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Market Outperform | $77 → $100 | $103.44 | -3.33% | 3 | Aug 20, 2024 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $17.87 | - | 1 | May 7, 2024 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $36.03 | +66.53% | 2 | Nov 29, 2023 |
Artivion
Oct 23, 2024
Initiates: Market Outperform
Price Target: $33
Current: $27.17
Upside: +21.46%
LeMaitre Vascular
Aug 20, 2024
Maintains: Market Outperform
Price Target: $77 → $100
Current: $103.44
Upside: -3.33%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $17.87
Upside: -
AtriCure
Nov 29, 2023
Reiterates: Market Outperform
Price Target: $60
Current: $36.03
Upside: +66.53%